This demonstrates that tumor derived organoids can recapitulate three critical components of antigen presentation: (1) tumor organoids produce tumor antigens, (2) dendritic cells can process and present tumor antigens in organoid models, and (3) CD8+ T cells can be activated by dendritic cells resulting in tumor cell lysis in a TCR-dependent manner. The gene discussed is CD8A; the disease is neoplasm.